We are live on ! Find out more
AA

ALPS Advisors Portfolio holdings

AUM $21.3B
1-Year Est. Return 21.71%
This Fund
S&P 500
This Quarter Est. Return
-4.57%
1 Year Est. Return
+21.71%
3 Year Est. Return
+77.63%
5 Year Est. Return
+121.1%
10 Year Est. Return
+198.29%
AUM
$12.2B
AUM Growth
-$499M
Cap. Flow
-$541M
Cap. Flow %
-4.43%
Top 10 Hldgs %
52.02%
Holding
832
New
248
Increased
200
Reduced
214
Closed
170

Sector Composition

Rank Sector Weight
1 Energy 71.16%
2 Materials 2.11%
3 Consumer Discretionary 1.46%
4 Healthcare 1.42%
5 Industrials 1.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CNP icon
151
CenterPoint Energy
CNP
$29.1B
$1.93M 0.02%
94,625
+15,083
+19% +$330K
NGD
152
DELISTED
New Gold Inc
NGD
$1.9M 0.02%
561,696
+113,239
+25% +$446K
AG icon
153
First Majestic Silver
AG
$8.05B
$1.9M 0.02%
350,518
-22,777
-6% -$134K
HST icon
154
Host Hotels & Resorts
HST
$16.8B
$1.89M 0.02%
93,771
+716
+0.8% +$16K
ESS icon
155
Essex Property Trust
ESS
$18.9B
$1.82M 0.01%
7,919
+78
+1% +$17.7K
GEVA
156
DELISTED
SYNAGEVA BIOPHARMA CORP COM STK (DE)
GEVA
$1.8M 0.01%
+18,432
New +$1.95M
IPXL
157
DELISTED
Impax Laboratories, Inc.
IPXL
$1.66M 0.01%
+35,425
New +$1.41M
NBIX icon
158
Neurocrine Biosciences
NBIX
$17.7B
$1.65M 0.01%
+41,481
New +$1.48M
DE icon
159
Deere & Co
DE
$170B
$1.62M 0.01%
18,423
-12,207
-40% -$1.08M
ACAD icon
160
Acadia Pharmaceuticals
ACAD
$4.25B
$1.61M 0.01%
+49,565
New +$1.7M
PCRX icon
161
Pacira BioSciences
PCRX
$1.02B
$1.6M 0.01%
+18,035
New +$1.83M
ADM icon
162
Archer Daniels Midland
ADM
$41.4B
$1.6M 0.01%
33,742
-9,248
-22% -$440K
SLG icon
163
SL Green Realty
SLG
$3.88B
$1.54M 0.01%
12,428
+277
+2% +$34.3K
HZNP
164
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$1.53M 0.01%
+59,066
New +$1.08M
ASPX
165
DELISTED
AUSPEX PHARMACEUTICALS INC COM STK (DE)
ASPX
$1.52M 0.01%
+15,173
New +$1.01M
SSRI
166
DELISTED
Silver Standard Resources
SSRI
$1.51M 0.01%
333,980
-13,898
-4% -$77.2K
MAC icon
167
Macerich
MAC
$7.32B
$1.47M 0.01%
17,395
+192
+1% +$16.8K
O icon
168
Realty Income
O
$61.2B
$1.42M 0.01%
28,458
+332
+1% +$16.6K
KIM icon
169
Kimco Realty
KIM
$17.6B
$1.37M 0.01%
50,907
+449
+0.9% +$12.1K
CLDX icon
170
Celldex Therapeutics
CLDX
$2.77B
$1.34M 0.01%
+3,210
New +$1.15M
CVX icon
171
Chevron
CVX
$388B
$1.34M 0.01%
12,734
-2,607
-17% -$278K
LGND icon
172
Ligand Pharmaceuticals
LGND
$6.02B
$1.3M 0.01%
+26,975
New +$1.03M
CF icon
173
CF Industries
CF
$19.2B
$1.26M 0.01%
22,180
+5,235
+31% +$312K
CLVS
174
DELISTED
Clovis Oncology, Inc.
CLVS
$1.26M 0.01%
+16,946
New +$1.2M
FRT icon
175
Federal Realty Investment Trust
FRT
$10.9B
$1.25M 0.01%
8,479
+190
+2% +$27.3K

Similar funds

ALPS Advisors's Q1 2015 Portfolio in Review

As of Q1 2015, ALPS Advisors held 832 positions worth $12.2B, down 3.9% from $12.7B the previous quarter. Its ten largest holdings account for 52% of the portfolio.

ALPS Advisors withdrew a net $541M in Q1 2015, closing 170 positions and reducing 214 holdings. Its most notable exit was WILLIAMS PARTNERS L.P. COM UTS REPTG L.P. INT, an estimated $434M position sold in full.

By sector, the portfolio is most concentrated in Energy at 71% of assets, down from 73% a quarter earlier, followed by Materials and Consumer Discretionary.

Against the trend, ALPS Advisors opened a new position in iShares Core S&P 500 ETF worth $191M.

  • ALPS Advisors's largest Q1 2015 buy was iShares Core S&P 500 ETF: 920,757 shares worth $191M.
  • ALPS Advisors added most to Williams Partners L.P. in Q1 2015, an estimated $362M increase.
  • ALPS Advisors's biggest Q1 2015 reduction was Lumen, cutting an estimated $406M.
  • ALPS Advisors fully exited WILLIAMS PARTNERS L.P. COM UTS REPTG L.P. INT in Q1 2015, selling an estimated $434M.
  • ALPS Advisors's ten largest holdings make up 52% of its $12.2B portfolio in Q1 2015.
  • ALPS Advisors opened 248 new positions and closed 170 in Q1 2015.
  • ALPS Advisors's portfolio value fell 3.9% quarter-over-quarter to $12.2B.

Based on ALPS Advisors's 13F filing for Q1 2015, filed 15 May 2015.